Reports for CHEPLAPHARM ARZNEIMITTEL GMBH

Company Name

CHEPLAPHARM ARZNEIMITTEL GMBH

Totals

Shortage reports

48

Actual shortage: 7 (15%)
Anticipated shortage: 0 (0%)
Avoided shortage: 1 (2%)
Resolved: 40 (83%)

Discontinuation Reports

4

To be discontinued: 0 (0%)
Discontinued: 4 (100%)
Reversed: 0 (0%)

Late reports

4 (8%)

Overdue reports

4 (57%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
VEPESID 50MG CAPSULE Avoided shortage 2018-05-16 2018-12-20 49573
INHIBACE 2.5MG TABLET Actual shortage 2018-11-26 2019-02-19 67581
ANANDRON 50MG TABLET Actual shortage 2023-09-14 2023-11-18 204346
SUPREFACT 1MG SOLUTION Actual shortage 2024-02-27 2024-02-29 220741
SUPREFACT DEPOT 3 MONTHS 9.45MG IMPLANT Actual shortage 2023-10-24 2023-10-25 207981
ONE-ALPHA 2MCG SOLUTION LIQUID Actual shortage 2023-12-13 2024-01-22 213256
FUNGIZONE 50MG POWDER FOR SOLUTION Actual shortage 2024-03-08 2024-03-12 221737
LOSEC MUPS 20MG TABLET (DELAYED-RELEASE) Actual shortage 2023-12-13 2024-04-26 213267

Showing 41 to 48 of 48

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
LOSEC 20MG TABLET (DELAYED-RELEASE) Discontinued 2021-11-19 2021-11-19 149669
SUPREFACT 100MCG SOLUTION Discontinued 2021-12-13 2021-12-13 151039
XELODA 150MG TABLET Discontinued 2022-11-30 2022-12-01 176355
XELODA 500MG TABLET Discontinued 2022-11-30 2022-12-01 176359

Showing 1 to 4 of 4